VACCIBODY IN THE MEDIA

Vaccibody secures NOK 230 million

Published: Feb 18, 2019 – Nordic Life Science News

Vaccibody teams up with Roche in I-O trial

Published: Feb 15, 2019 – The Pharma Letter

New collaboration aims to treat cervical cancer

Published: Feb 15, 2019 – Oslo Cancer Cluster

Vaccibody and Roche join forces in new study

Vaccibody allierer sig med Roche i nyt fase 2-studie

Published: Feb 13, 2019 – Medwatch

Prestigious partnership for Vaccibody

Published: Sep 27, 2018 – Oslo Cancer Cluster

‘Vaccibody’s therapeutic HPV vaccine obtains proof-of-concept in phase 2a study’

Vaccibodys terapeutiske HPV-vaccine opnår proof-of-concept i fase 2a-studie

Published: Sep 27, 2018 – Medwatch

‘Norwegian company of Danish biotech veteran enters collaboration with BMS partner’

Dansk biotekveterans norske selskab indgår samarbejde med BMS-partner

Published: Sep 21, 2018 – Medwatch

‘Breakthrough – Norwegian company with new world-class cancer vaccine’

Norsk firma med ny kreftvaksine i verdensklasse: – Revolusjonerende

Published: Apr 11, 2018 – VG

‘Vaccibody is getting ready for Phase I with new data’

Vaccibody varmer op til fase 1 med nye data

Published: Jan 10, 2018 – Medwatch

‘Vaccibody to initiate new clinical trial and to start hunt for partner’

Vaccibody laver nye kliniske fremstød og starter partnerjagt

Published: Dec 13, 2017 – Medwatch

‘Norwegian world-class vaccine technology’

Norsk vaksineteknologi i verdenstoppen

Published: Sep 14, 2017 – Kreftforeningen

‘Norwegian company with new vaccine technology’

Norsk firma med ny vaksineteknologi

Published: May 8, 2017 – Bioteknologirådet

Vaccibody moves forward with clinical study

Published: Apr 10, 2017 – Nordic Life Science

Inven2 – Company presentation

Published: Feb 14, 2017 – Inven2

‘Investors queuing up for cancer vaccine’

Investorer i kø for kreftvaksine

Published: Jan 26, 2017 – Finansavisen

‘Queue to buy shares’ 

Kø for å kjøpe aksjer i kreftselskap – Da Vaccibody ba om 200 millioner kroner til en ny kreftvaksine, kom investorene løpende

Published: Jan 26, 2017 – Dagbladet

‘Has already saved lives: Agnete (38) can revolutionize future cancer treatment’

Har allerede reddet liv: Agnete (38) kan revolusjonere fremtidens kreftbehandling

Published: Oct 2, 2016 – TV2

‘Norwegian vaccine breakthrough’

Norsk vaksine-gjennombrudd: Har begynt testing på mennesker – Utenpå var jeg voksen og ordentlig, men inni meg var det høy puls.

Published: Sep 17, 2015 – Teknisk Ukeblad

Vaccibody name Martin Bonde as CEO

Published: Jul 1, 2015 – PMLive

‘Creating intelligent vaccines that might cure cancer’

Lager intelligent vaksine de håper kan kurere kreft #NorgeEtterOljen.

Published: Feb 8, 2015 – Teknisk Ukeblad

From the lab to vaccines that fight cancer and infectious diseases

Published: Jan 25, 2016 – UiO:Life Science

‘Agnete (37) is ready to test Norwegian cancer vaccine in humans’

Agnete (37) er klar for å teste norsk kreftvaksine på mennesker – Etter svært lovende resultater i forsøk på dyr, skal en norsk vaksine mot livmorhalskreft nå testes på mennesker.

Published: Jun 15, 2015 – TV2